SAN DIEGO — In patients with heart failure, treatment with finerenone provides some benefits in reducing the risk for macroalbuminuria. However, no significant changes are observed in estimated glomerular filtration rate (eGFR)-based kidney outcomes, an analysis of the recently published FINEARTS-HF trial shows. “Among patients with heart failure with mildly reduced or preserved ejection fraction ...
.png)
Copyright © 2023 cape-breton.com. Toady's News. All Rights Reserved
